Trial Details

COMPLETED
Basic Information
Clinical ID c796
Identifier NCT01493960
Trial Title The Efficacy and Safety of Cobitolimod (Kappaproct) in Chronic Active Treatment Refractory Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative
Interventions DRUG: Cobitolimod|DRUG: Placebo
Participant Information
Sponsor InDex Pharmaceuticals
City Hradec Kralove
Country/Region Czechia
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-12-11
Primary Completion Date 2025-06-13
Completion Date 2025-03-14